A, P., S, H., M, W., EG, P., D, P., F, P., & J, T. (2020). Rapid and Complete Response to Combination Anti-CTLA-4 and Anti-PD-1 Checkpoint Inhibitor Therapy in a Patient With Stage IV Refractory End-stage Epithelioid Sarcoma: A Case Report. Journal of immunotherapy (Hagerstown, Md. : 1997), 43(9), 286. https://doi.org/10.1097/CJI.0000000000000332
Chicago Style (17th ed.) CitationA, Pecora, Halpern S, Weber M, Paleoudis EG, Panush D, Patterson F, and Toretsky J. "Rapid and Complete Response to Combination Anti-CTLA-4 and Anti-PD-1 Checkpoint Inhibitor Therapy in a Patient With Stage IV Refractory End-stage Epithelioid Sarcoma: A Case Report." Journal of Immunotherapy (Hagerstown, Md. : 1997) 43, no. 9 (2020): 286. https://doi.org/10.1097/CJI.0000000000000332.
MLA (9th ed.) CitationA, Pecora, et al. "Rapid and Complete Response to Combination Anti-CTLA-4 and Anti-PD-1 Checkpoint Inhibitor Therapy in a Patient With Stage IV Refractory End-stage Epithelioid Sarcoma: A Case Report." Journal of Immunotherapy (Hagerstown, Md. : 1997), vol. 43, no. 9, 2020, p. 286, https://doi.org/10.1097/CJI.0000000000000332.